Healthcare services provider AdaptHealth Corp. (NASDAQ: AHCO) will be reporting earnings this Tuesday before the bell. Here’s what to expect.
AdaptHealth met analysts’ revenue expectations last quarter, reporting revenues of $800.4 million, flat year on year. It was a slower quarter for the company, with a significant miss of analysts’ EPS estimates and revenue in line with analysts’ estimates.
Is AdaptHealth a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting AdaptHealth’s revenue to be flat year on year at $800.1 million, in line with its flat revenue from the same quarter last year. Adjusted earnings are expected to come in at $0.24 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. AdaptHealth has missed Wall Street’s revenue estimates twice over the last two years.
Looking at AdaptHealth’s peers in the senior health, home health & hospice segment, some have already reported their Q3 results, giving us a hint as to what we can expect. BrightSpring Health Services delivered year-on-year revenue growth of 14.7%, beating analysts’ expectations by 5.3%, and Option Care Health reported revenues up 12.2%, topping estimates by 1.4%. BrightSpring Health Services’s stock price was unchanged after the resultswhile Option Care Health was down 9.2%.
Read our full analysis of BrightSpring Health Services’s results here and Option Care Health’s results here.
Investors in the senior health, home health & hospice segment have had steady hands going into earnings, with share prices flat over the last month. AdaptHealth’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $13 (compared to the current share price of $8.99).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
